Cardiac Arrhythmias

1. Front Matter

   Pages III-XVIII

   PDF

2. Introduction

   • Dennis Krikler

   Pages 1-2

3. Differentiation Between “Normal” and “Abnormal” in Ambulatory Electrocardiography

   • P. Bjerregaard

   Pages 3-12

4. Identification of the Patient at High Risk of Sudden Cardiac Death

   • J. Morganroth

   Pages 13-19

5. Efficacy of Oral Propafenone in Supraventricular and Ventricular Arrhythmias: Experience with 47 Cases

   • P. Coumel, J.-F Leclercq

   Pages 21-35

6. The Possible Relevance of Late Potentials for the Identification of Patients Needing Antiarrhythmic Treatment

   • G. Breithardt, M. Borggrefe, U. Karbenn, K. Haerten, J. Ostermeyer, L. Seipel

   Pages 37-52

7. Simulation Studies for the Interpretation of Delayed Potentials

   • R. Frank, G. Fontaine, M. Pierfitte, Y. Grosgogeat

   Pages 53-61

8. Electrophysiologic Testing in Patients with Ventricular Tachycardia

   • E. N. Prystowsky, G. V. Naccarelli, J. J. Heger, D. P. Zipes

   Pages 63-70

9. Results of Invasive Methods

   • H. J. Wellens

   Pages 71-74

10. Specific Antiarrhythmic Drugs for Specific Arrhythmias

    • R. W. F. Campbell

    Pages 75-81

11. Sudden Cardiac Death: Prognosis of Long-term Antiarrhythmic Therapy

    • M. Manz, G. Steinbeck, B. Lüderitz

    Pages 83-90

12. Basic Electrophysiological Actions of Propafenone in Heart Muscle

    • M. Kohlhardt

    Pages 91-101

13. The Pharmacology of Propafenone

    • H. Scholz

    Pages 103-111

14. Clinical Pharmacology of Propafenone

    • H. Neuss, M. Schlepper

    Pages 113-124

15. Pharmacokinetic and Metabolic Studies on Propafenone in Volunteers

    • M. Hollmann, H. G. Hege, E. Brode, V. Bühler, D. Hotz, S. Kaumeier et al.

    Pages 125-132

16. Effects of Propafenone on Hemodynamics and Cardiac Inotropy

    • M. Schlepper, H. Neuss

    Pages 133-139

17. Interaction Between Propafenone and Other Drugs

    • K. Steinbach, K. Frohner, F. Meisl, G. Unger

    Pages 141-147

18. Comparison of the Efficacy of Propafenone and Lidocaine in Patients with Acute Myocardial Infarction and Ventricular Extrasystoles: Result of a 24-h Holter Monitoring

    • N. Rehnqvist

    Pages 149-150

19. Observations on the Antiarrhythmic Effects of Rytmonorm

    • Ku Fu-sheng, Lin Jui-Chin, Liu Pei-Tsun, Li Qing-lang, Chang Jang-thi, Shen Lu-hua et al.

    Pages 151-158

20. Comparative Study of the Therapeutic Effect of Propafenone and Disopyramide in the Oral Treatment of Chronic Ventricular Premature Beats

    • J. Clementy, M. Dallocchio, H. Bricaud

    Pages 159-169

Asked to organize an international meeting on Propafenone (Ryt­ monorm) we had to question ourselves, whether to accept this offer just as interested physicians or in our capacity as chairmen of the study group on arrhythmias and intracardiac electrography of the European Society of Cardiology. Considerung the "pros and contras" and well aware that one can easily be regarded as "product promoter" we, nevertheless, choose to organize the Symposion in association with the study group. We felt justified to do so for a number of reasons: Arrhyth­ mias and their treatment as well as the tools to detect the first and to control the latter are well within the scope of the study group. An international symposion provided the opportunity to have the "state of the art" in arrhythmias and antiarrhythmic treatment thoroughly reviewed by internationally renowned investigators, thus serving an educational purpose. Furthermore it was the intention and aim of the meeting to have what is known about a fairly new drug presented in a critical manner and to point out what is not known, but should be known. It is in that context the presentations of the free session should be judged. To the careful reader it will become apparent that much which was not said, can be read "between the lines".

• arrhythmia
• cardiology
• diagnosis
• drug
• drugs
• education
• electrocardiography
• heart
• hemodynamics
• myocardial infarction
• sudden cardiac death
• therapy
• treatment

• Kerckhoff-Klinik of the Max-Planck-Society, Bad Nauheim, Germany

  M. Schlepper

• Department of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden

  B. Olsson

Policies and ethics